植入犬左束支部的生物起器提供了心室逃逸节奏,这些节奏在生理上具有可接受的速度
Alexei N Plotnikov1, Eugene A Sosunov, Jihong Qu
1Center for Molecular Therapeutics, Department of Pharmacology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.
Circulation
|January 22, 2004
概括
使用左束分支系统中的HCN2基因进行基因治疗,成功地在狗中制造出生物节拍器,提供生理上可接受的心率. 需要进一步的研究来证实长期的有效性.
科学领域:
- 心血管研究研究心血管研究
- 基因治疗 基因治疗
- 电子生理学 电子生理学
背景情况:
- 左束支 (LBB) 系统是心脏电导的关键组成部分.
- 开发一个生物起器可以为心脏提供一种新的治疗策略.
- 众所周知,HCN2基因在心脏节拍中发挥作用.
研究的目的:
- 调查HCN2基因在LBB系统中诱导心脏起器功能的潜力.
- 为了确定这种基因治疗方法是否可以实现生理心率.
主要方法:
- 携带HCN2和GFP的腺病毒载体被注射到狗的LBB中.
- 对照组接受了单独的GFP或盐水.
- 动物通过心电图进行监测,死后对心脏进行基因表达和电生理学特性分析.
主要成果:
- 注射后,观察到过渡性心室节律失常,随后建立了鼻节律.
- 与对照组相比,接受HCN2治疗的狗在阴道刺激期间表现出更快的腹腔逃生节奏.
- 活体分析证实,治疗动物的LBB增加了自动性和HCN2过度表达.
结论:
- 用HCN2向LBB系统的基因治疗可以以可接受的速度诱导生物心脏起器活性.
- 这种方法对创建心室逃生节奏有希望.
- 长期稳定性和可行性需要进一步研究.
相关概念视频
Electrophysiology of Normal Cardiac Rhythm
7.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K
Mechanism of Cardiac Arrhythmias
2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Conduction System of the Heart
13.5K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
13.5K
Disturbances in Heart Rhythm
5.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.3K
Dysrhythmias IV: Characteristics of Bradyarrhythmias
788
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
788
Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597


